Coty Class Action Lawsuit Reminder
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 03 2026
0mins
Should l Buy COTY?
Source: Globenewswire
- Class Action Notice: Rosen Law Firm reminds investors who purchased Coty Inc. (NYSE: COTY) common stock between November 5, 2025, and February 4, 2026, that they must apply to be lead plaintiff by May 22, 2026, to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that Coty made false and/or misleading statements during the Class Period, concealing the true state of its slowing growth in the beauty market, particularly the underperformance in the Consumer Beauty segment, which led to investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, showcasing its strong track record and expertise in this field.
- Participation Instructions: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, ensuring they select qualified legal counsel to represent them effectively in the lawsuit and avoid inexperienced intermediaries.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COTY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COTY
Wall Street analysts forecast COTY stock price to rise
12 Analyst Rating
1 Buy
9 Hold
2 Sell
Hold
Current: 2.280
Low
2.50
Averages
4.30
High
10.00
Current: 2.280
Low
2.50
Averages
4.30
High
10.00
About COTY
Coty Inc. is a beauty company with a portfolio of brands across fragrance, color cosmetics, and skin and body care. The Company has a diverse portfolio of brands, which includes both owned and licensed. Its brand portfolio is classified into two segments: Consumer beauty and Prestige. The consumer beauty brands include Adidas, Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Mexx, LeGer by Lena Gercke, Monange, Nautica, Paixao, Rimmel, Risque, Sally Hansen, and Vera Wang. Its prestige brands include Burberry, Calvin Klein, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Miu Miu, Orveda, and Tiffany & Co. Its mass beauty brands are primarily sold through hypermarkets, supermarkets, drug stores and pharmacies, mid-tier department stores, traditional food and drug retailers, and dedicated e-commerce retailers. It markets, sells and distributes its products in over 120 countries and territories.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Coty Class Action Lawsuit Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Coty Inc. (NYSE: COTY) common stock between November 5, 2025, and February 4, 2026, that they must apply to be lead plaintiff by May 22, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Coty made false and misleading statements during the class period, concealing the true state of its slowing growth in the beauty market, particularly the underperformance in the Consumer Beauty segment, which led to investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, being ranked No. 1 by ISS Securities Class Action Services in 2017, demonstrating its extensive experience and success in this field.
- Investor Action Advice: Investors can visit the Rosen Law Firm website or call toll-free for more information, emphasizing the importance of selecting qualified legal counsel to ensure proper representation in the lawsuit and avoid inexperienced intermediary firms.
See More
Class Action Lawsuits Filed for Multiple Companies
- Lufax Shareholder Lawsuit: Shareholders of Lufax Holding Ltd. have filed a class action due to the company's failure to disclose inadequate internal controls and misstated financial results during the period from April 7, 2023, to January 26, 2025, with a lead plaintiff deadline of May 20, 2026.
- Atara Biotherapeutics Lawsuit: Atara Biotherapeutics, Inc. shareholders initiated a lawsuit for the period from May 20, 2024, to January 9, 2026, alleging undisclosed manufacturing issues and clinical trial risks that jeopardized FDA approval prospects, with a lead plaintiff deadline of May 22, 2026.
- Coty Shareholder Class Action: Coty Inc. shareholders have filed a class action due to the company's failure to disclose underperformance in its Consumer Beauty segment and slowing market growth from November 5, 2025, to February 4, 2026, with a lead plaintiff deadline of May 22, 2026.
- Legal Consultation Information: The Law Offices of Frank R. Cruz remind investors who suffered losses during these periods to contact them for legal advice to protect their rights and interests.
See More
Coty Faces Class Action Lawsuit Amid Disappointing Earnings and Stock Plunge
- Class Action Filed: Pomerantz LLP has initiated a class action lawsuit against Coty, alleging securities fraud by the company and certain executives, with investors urged to apply as Lead Plaintiff by May 22, 2026, highlighting serious concerns over corporate governance and compliance.
- Disappointing Earnings Report: Coty's financial results announced on February 4 and 5, 2026, revealed worsening performance in the Consumer Beauty segment, leading the company to withdraw its fiscal year 2026 EBITDA guidance, reflecting negative impacts from macroeconomic factors and uncertain consumer demand.
- Significant Stock Decline: Following the earnings report, Coty's stock price fell by $0.77, or 22.45%, over two trading sessions, closing at $2.66 per share, indicating market pessimism regarding the company's future outlook.
- Executive Transition Impact: The recent change in Coty's CEO, coupled with disappointing results, suggests a lack of “operational discipline” within the company, which may further undermine investor confidence and market performance.
See More
Analysis of Coty Inc.'s Dividend Yield
- Dividend History Analysis: Coty Inc.'s dividend history chart indicates that while dividend amounts are unpredictable, the current 21.6% annualized dividend yield remains attractive amidst profitability fluctuations, potentially drawing investor interest.
- Volatility Assessment: With a trailing twelve-month volatility of 52% calculated from the last 250 trading days, Coty's stock exhibits significant price fluctuations, prompting investors to carefully evaluate the risk-reward balance.
- Options Trading Dynamics: On Tuesday, the put volume among S&P 500 components reached 2.00 million contracts, while call volume was at 4.58 million, indicating a preference for call options among investors, which may reflect optimistic market sentiment regarding Coty's future performance.
- Options Market Trends: The current put-call ratio stands at 0.44, significantly lower than the long-term median of 0.65, suggesting a bullish market sentiment where investors are likely seeking higher returns through options strategies.
See More
Coty Faces Securities Class Action Lawsuit Amid Operational Issues
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit related to stock purchases between November 5, 2025, and February 4, 2026, alleging that the company failed to disclose critical business trends, resulting in significant investor losses.
- Performance Decline: The Q2 2026 earnings report revealed a staggering over 70% drop in operating income for the Consumer Beauty segment year-over-year, while the Prestige fragrance segment also saw an 18% decline, severely impacting the company's profitability and market confidence.
- Management Changes: The abrupt departure of CEO Sue Nabi, which occurred without explanation, caused Coty's stock price to plummet over 8% in a single day, raising concerns among investors regarding corporate governance and future growth prospects.
- Legal Investigation: Hagens Berman is investigating whether Coty intentionally misled investors and is urging affected shareholders to submit their losses to support the class action lawsuit.
See More
Coty Shareholder Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Coty Inc. (NYSE:COTY) common stock between November 5, 2025, and February 4, 2026, that they must apply to be lead plaintiff by May 22, 2026, to participate in the class action and seek compensation.
- Fee Arrangement: Investors joining the Coty class action will incur no out-of-pocket costs, as the law firm operates on a contingency fee basis, ensuring legal support without financial burden for the investors.
- Lawsuit Background: The lawsuit alleges that Coty made false and misleading statements during the class period, concealing the true state of its slowing growth in the beauty market, which led to investor losses when the truth was revealed.
- Law Firm's Strength: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first in 2017 for the number of securities class action settlements, demonstrating its strong capabilities and experience in this field.
See More
Coty Class Action Lawsuit Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Coty Inc. (NYSE: COTY) common stock between November 5, 2025, and February 4, 2026, that they must apply to be lead plaintiff by May 22, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Coty made false and misleading statements during the class period, concealing the true state of its slowing growth in the beauty market, particularly the underperformance in the Consumer Beauty segment, which led to investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, being ranked No. 1 by ISS Securities Class Action Services in 2017, demonstrating its extensive experience and success in this field.
- Investor Action Advice: Investors can visit the Rosen Law Firm website or call toll-free for more information, emphasizing the importance of selecting qualified legal counsel to ensure proper representation in the lawsuit and avoid inexperienced intermediary firms.
See More
Class Action Lawsuits Filed for Multiple Companies
- Lufax Shareholder Lawsuit: Shareholders of Lufax Holding Ltd. have filed a class action due to the company's failure to disclose inadequate internal controls and misstated financial results during the period from April 7, 2023, to January 26, 2025, with a lead plaintiff deadline of May 20, 2026.
- Atara Biotherapeutics Lawsuit: Atara Biotherapeutics, Inc. shareholders initiated a lawsuit for the period from May 20, 2024, to January 9, 2026, alleging undisclosed manufacturing issues and clinical trial risks that jeopardized FDA approval prospects, with a lead plaintiff deadline of May 22, 2026.
- Coty Shareholder Class Action: Coty Inc. shareholders have filed a class action due to the company's failure to disclose underperformance in its Consumer Beauty segment and slowing market growth from November 5, 2025, to February 4, 2026, with a lead plaintiff deadline of May 22, 2026.
- Legal Consultation Information: The Law Offices of Frank R. Cruz remind investors who suffered losses during these periods to contact them for legal advice to protect their rights and interests.
See More
Coty Faces Class Action Lawsuit Amid Disappointing Earnings and Stock Plunge
- Class Action Filed: Pomerantz LLP has initiated a class action lawsuit against Coty, alleging securities fraud by the company and certain executives, with investors urged to apply as Lead Plaintiff by May 22, 2026, highlighting serious concerns over corporate governance and compliance.
- Disappointing Earnings Report: Coty's financial results announced on February 4 and 5, 2026, revealed worsening performance in the Consumer Beauty segment, leading the company to withdraw its fiscal year 2026 EBITDA guidance, reflecting negative impacts from macroeconomic factors and uncertain consumer demand.
- Significant Stock Decline: Following the earnings report, Coty's stock price fell by $0.77, or 22.45%, over two trading sessions, closing at $2.66 per share, indicating market pessimism regarding the company's future outlook.
- Executive Transition Impact: The recent change in Coty's CEO, coupled with disappointing results, suggests a lack of “operational discipline” within the company, which may further undermine investor confidence and market performance.
See More
Analysis of Coty Inc.'s Dividend Yield
- Dividend History Analysis: Coty Inc.'s dividend history chart indicates that while dividend amounts are unpredictable, the current 21.6% annualized dividend yield remains attractive amidst profitability fluctuations, potentially drawing investor interest.
- Volatility Assessment: With a trailing twelve-month volatility of 52% calculated from the last 250 trading days, Coty's stock exhibits significant price fluctuations, prompting investors to carefully evaluate the risk-reward balance.
- Options Trading Dynamics: On Tuesday, the put volume among S&P 500 components reached 2.00 million contracts, while call volume was at 4.58 million, indicating a preference for call options among investors, which may reflect optimistic market sentiment regarding Coty's future performance.
- Options Market Trends: The current put-call ratio stands at 0.44, significantly lower than the long-term median of 0.65, suggesting a bullish market sentiment where investors are likely seeking higher returns through options strategies.
See More
Coty Faces Securities Class Action Lawsuit Amid Operational Issues
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit related to stock purchases between November 5, 2025, and February 4, 2026, alleging that the company failed to disclose critical business trends, resulting in significant investor losses.
- Performance Decline: The Q2 2026 earnings report revealed a staggering over 70% drop in operating income for the Consumer Beauty segment year-over-year, while the Prestige fragrance segment also saw an 18% decline, severely impacting the company's profitability and market confidence.
- Management Changes: The abrupt departure of CEO Sue Nabi, which occurred without explanation, caused Coty's stock price to plummet over 8% in a single day, raising concerns among investors regarding corporate governance and future growth prospects.
- Legal Investigation: Hagens Berman is investigating whether Coty intentionally misled investors and is urging affected shareholders to submit their losses to support the class action lawsuit.
See More
Coty Shareholder Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Coty Inc. (NYSE:COTY) common stock between November 5, 2025, and February 4, 2026, that they must apply to be lead plaintiff by May 22, 2026, to participate in the class action and seek compensation.
- Fee Arrangement: Investors joining the Coty class action will incur no out-of-pocket costs, as the law firm operates on a contingency fee basis, ensuring legal support without financial burden for the investors.
- Lawsuit Background: The lawsuit alleges that Coty made false and misleading statements during the class period, concealing the true state of its slowing growth in the beauty market, which led to investor losses when the truth was revealed.
- Law Firm's Strength: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first in 2017 for the number of securities class action settlements, demonstrating its strong capabilities and experience in this field.
See More
